90 related articles for article (PubMed ID: 25057880)
1. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
[TBL] [Abstract][Full Text] [Related]
2. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.
Choi M; Scholl UI; Yue P; Björklund P; Zhao B; Nelson-Williams C; Ji W; Cho Y; Patel A; Men CJ; Lolis E; Wisgerhof MV; Geller DS; Mane S; Hellman P; Westin G; Åkerström G; Wang W; Carling T; Lifton RP
Science; 2011 Feb; 331(6018):768-72. PubMed ID: 21311022
[TBL] [Abstract][Full Text] [Related]
3. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.
Oki K; Plonczynski MW; Luis Lam M; Gomez-Sanchez EP; Gomez-Sanchez CE
Endocrinology; 2012 Apr; 153(4):1774-82. PubMed ID: 22315453
[TBL] [Abstract][Full Text] [Related]
4. Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism.
Yamazaki Y; Nakamura Y; Omata K; Ise K; Tezuka Y; Ono Y; Morimoto R; Nozawa Y; Gomez-Sanchez CE; Tomlins SA; Rainey WE; Ito S; Satoh F; Sasano H
J Clin Endocrinol Metab; 2017 Apr; 102(4):1182-1192. PubMed ID: 28388725
[TBL] [Abstract][Full Text] [Related]
5. Urine steroid metabolomics as a diagnostic tool in primary aldosteronism.
Prete A; Lang K; Pavlov D; Rhayem Y; Sitch AJ; Franke AS; Gilligan LC; Shackleton CHL; Hahner S; Quinkler M; Dekkers T; Deinum J; Reincke M; Beuschlein F; Biehl M; Arlt W
J Steroid Biochem Mol Biol; 2024 Mar; 237():106445. PubMed ID: 38104729
[TBL] [Abstract][Full Text] [Related]
6. Single-Nucleus Analysis Reveals Tumor Heterogeneity of Aldosterone-Producing Adenoma.
Murakami M; Hara K; Ikeda K; Horino M; Okazaki R; Niitsu Y; Takeuchi A; Aoki J; Shiba K; Tsujimoto K; Komiya C; Nakamura Y; Kurata M; Akashi T; Fujii Y; Yamada T
Hypertension; 2024 Feb; 81(2):361-371. PubMed ID: 38095094
[TBL] [Abstract][Full Text] [Related]
7. Double somatic mutations in
Nanba K; Blinder AR; Udager AM; Hirokawa Y; Miura T; Okuno H; Moriyoshi K; Yamazaki Y; Sasano H; Yasoda A; Satoh-Asahara N; Rainey WE; Tagami T
Front Endocrinol (Lausanne); 2024; 15():1286297. PubMed ID: 38505749
[TBL] [Abstract][Full Text] [Related]
8. The influence of cortisol co-secretion on clinical characteristics and postoperative outcomes in unilateral primary aldosteronism.
Jiang Y; Zhou L; Zhang C; Su T; Jiang L; Zhou W; Zhong X; Wu L; Wang W
Front Endocrinol (Lausanne); 2024; 15():1369582. PubMed ID: 38745957
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Outcomes of KCNJ5 mutated Aldosterone-Producing Adenoma: A Systematic Review.
Kato H; Kitamoto T; Kimura S; Sunouchi T; Hoshino Y; Hidaka N; Tsurutani Y; Ito N; Makita N; Nishikawa T; Nangaku M; Inoue K
Endocr Pract; 2024 Apr; ():. PubMed ID: 38657793
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone-Producing Cell Clusters Frequently Harbor Somatic Mutations and Accumulate With Age in Normal Adrenals.
Omata K; Anand SK; Hovelson DH; Liu CJ; Yamazaki Y; Nakamura Y; Ito S; Satoh F; Sasano H; Rainey WE; Tomlins SA
J Endocr Soc; 2017 Jul; 1(7):787-799. PubMed ID: 29264530
[TBL] [Abstract][Full Text] [Related]
11. miR-221 and -222 target CACNA1C and KCNJ5 leading to altered cardiac ion channel expression and current density.
Binas S; Knyrim M; Hupfeld J; Kloeckner U; Rabe S; Mildenberger S; Quarch K; Strätz N; Misiak D; Gekle M; Grossmann C; Schreier B
Cell Mol Life Sci; 2020 Mar; 77(5):903-918. PubMed ID: 31312877
[TBL] [Abstract][Full Text] [Related]
12. De novo variants in
Li J; Mei S; Mao X; Wan L; Wang H; Xiao B; Song Y; Gu W; Liu Y; Long L
J Med Genet; 2024 Mar; 61(4):319-324. PubMed ID: 37963718
[TBL] [Abstract][Full Text] [Related]
13. Primary aldosteronism: molecular medicine meets public health.
Azizan EAB; Drake WM; Brown MJ
Nat Rev Nephrol; 2023 Dec; 19(12):788-806. PubMed ID: 37612380
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and metabolic characters of
Chang YY; Lee BC; Chen ZW; Tsai CH; Chang CC; Liao CW; Pan CT; Peng KY; Chou CH; Lu CC; Wu VC; Hung CS; Lin YH;
Front Endocrinol (Lausanne); 2023; 14():1061704. PubMed ID: 36950676
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome.
Santana LS; Guimaraes AG; Almeida MQ
Front Endocrinol (Lausanne); 2022; 13():927669. PubMed ID: 35813615
[TBL] [Abstract][Full Text] [Related]
16. Genetic Alterations in Benign Adrenal Tumors.
Pitsava G; Stratakis CA
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625779
[TBL] [Abstract][Full Text] [Related]
17. Approaches to Gene Mutation Analysis Using Formalin-Fixed Paraffin-Embedded Adrenal Tumor Tissue From Patients With Primary Aldosteronism.
Nanba K; Rainey WE; Udager AM
Front Endocrinol (Lausanne); 2021; 12():683588. PubMed ID: 34267727
[TBL] [Abstract][Full Text] [Related]
18. Update on Genetics of Primary Aldosteronism.
Itcho K; Oki K; Ohno H; Yoneda M
Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33920271
[TBL] [Abstract][Full Text] [Related]
19. Primary aldosteronism diagnostics:
Rege J; Turcu AF; Rainey WE
Gland Surg; 2020 Feb; 9(1):3-13. PubMed ID: 32206594
[TBL] [Abstract][Full Text] [Related]
20. Molecular and Electrophysiological Analyses of ATP2B4 Gene Variants in Bilateral Adrenal Hyperaldosteronism.
Hattangady NG; Foster J; Lerario AM; Ponce-Balbuena D; Rege J; Monticone S; Rainey WE; Mulatero P; Else T
Horm Cancer; 2020 Feb; 11(1):52-62. PubMed ID: 32002807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
